140 related articles for article (PubMed ID: 15059880)
1. The matrix metalloproteinase inhibitor prinomastat enhances photodynamic therapy responsiveness in a mouse tumor model.
Ferrario A; Chantrain CF; von Tiehl K; Buckley S; Rucker N; Shalinsky DR; Shimada H; DeClerck YA; Gomer CJ
Cancer Res; 2004 Apr; 64(7):2328-32. PubMed ID: 15059880
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
Ferrario A; Fisher AM; Rucker N; Gomer CJ
Cancer Res; 2005 Oct; 65(20):9473-8. PubMed ID: 16230411
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
Ferrario A; von Tiehl KF; Rucker N; Schwarz MA; Gill PS; Gomer CJ
Cancer Res; 2000 Aug; 60(15):4066-9. PubMed ID: 10945611
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 inhibitor treatment enhances photodynamic therapy-mediated tumor response.
Ferrario A; Von Tiehl K; Wong S; Luna M; Gomer CJ
Cancer Res; 2002 Jul; 62(14):3956-61. PubMed ID: 12124326
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy: combined modality approaches targeting the tumor microenvironment.
Gomer CJ; Ferrario A; Luna M; Rucker N; Wong S
Lasers Surg Med; 2006 Jun; 38(5):516-21. PubMed ID: 16607618
[TBL] [Abstract][Full Text] [Related]
6. Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.
Ferrario A; Luna M; Rucker N; Wong S; Gomer CJ
Lasers Surg Med; 2011 Sep; 43(7):644-50. PubMed ID: 22057492
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo matrix metalloproteinase expression after photodynamic therapy with a liposomal formulation of aminolevulinic acid and its methyl ester.
Osiecka B; Jurczyszyn K; Symonowicz K; Bronowicz A; Ostasiewicz P; Czapińska E; Hotowy K; Krzystek-Korpacka M; Gebarowska E; Izykowska I; Dziegiel P; Terlecki G; Ziółkowski P
Cell Mol Biol Lett; 2010 Dec; 15(4):630-50. PubMed ID: 20865364
[TBL] [Abstract][Full Text] [Related]
8. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.
Ferrario A; Rucker N; Wong S; Luna M; Gomer CJ
Cancer Res; 2007 May; 67(10):4989-95. PubMed ID: 17510430
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts.
Peng Q; Warloe T; Moan J; Godal A; Apricena F; Giercksky KE; Nesland JM
Cancer Res; 2001 Aug; 61(15):5824-32. PubMed ID: 11479222
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression induced by photofrin photodynamic therapy involves the p38 MAPK pathway.
Luna M; Wong S; Ferrario A; Gomer CJ
Photochem Photobiol; 2008; 84(2):509-14. PubMed ID: 18282182
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of photodynamic therapy by 2,5-dimethyl celecoxib, a non-cyclooxygenase-2 inhibitor analog of celecoxib.
Ferrario A; Lim S; Xu F; Luna M; Gaffney KJ; Petasis NA; Schönthal AH; Gomer CJ
Cancer Lett; 2011 May; 304(1):33-40. PubMed ID: 21339042
[TBL] [Abstract][Full Text] [Related]
12. Avastin enhances photodynamic therapy treatment of Kaposi's sarcoma in a mouse tumor model.
Ferrario A; Gomer CJ
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):251-9. PubMed ID: 16566722
[TBL] [Abstract][Full Text] [Related]
13. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice.
Makowski M; Grzela T; Niderla J; ŁAzarczyk M; Mróz P; Kopeé M; Legat M; Strusińska K; Koziak K; Nowis D; Mrówka P; Wasik M; Jakóbisiak M; Gołab J
Clin Cancer Res; 2003 Nov; 9(14):5417-22. PubMed ID: 14614028
[TBL] [Abstract][Full Text] [Related]
15. Enzyme-activatable imaging probe reveals enhanced neutrophil elastase activity in tumors following photodynamic therapy.
Mitra S; Modi KD; Foster TH
J Biomed Opt; 2013 Oct; 18(10):101314. PubMed ID: 23897439
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of matrix metalloproteinases in photodamaged skin by photodynamic therapy.
Almeida Issa MC; Piñeiro-Maceira J; Farias RE; Pureza M; Raggio Luiz R; Manela-Azulay M
Br J Dermatol; 2009 Sep; 161(3):647-53. PubMed ID: 19519826
[TBL] [Abstract][Full Text] [Related]
17. Early combined treatment with carboplatin and the MMP inhibitor, prinomastat, prolongs survival and reduces systemic metastasis in an aggressive orthotopic lung cancer model.
Liu J; Tsao MS; Pagura M; Shalinsky DR; Khoka R; Fata J; Johnston MR
Lung Cancer; 2003 Dec; 42(3):335-44. PubMed ID: 14644522
[TBL] [Abstract][Full Text] [Related]
18. Induction of systemic neutrophil response in mice by photodynamic therapy of solid tumors.
Cecic I; Parkins CS; Korbelik M
Photochem Photobiol; 2001 Nov; 74(5):712-20. PubMed ID: 11723800
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy down-regulates the invasion promoting factors in human oral cancer.
Sharwani A; Jerjes W; Hopper C; Lewis MP; El-Maaytah M; Khalil HS; Macrobert AJ; Upile T; Salih V
Arch Oral Biol; 2006 Dec; 51(12):1104-11. PubMed ID: 16889746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
